Family-based therapy for women in specialty courts with opioid use and sex-trade involvement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized trial compares adapted Multi-Dimensional Family Therapy added to specialty treatment court services versus treatment court services alone. Dyads consisting of a participant and a participating family member will be enrolled and followed with baseline and post-intervention assessments to gauge feasibility and acceptability. The study also explores preliminary signals of efficacy, though it is not powered to determine treatment effects. The intervention is co-designed to address the unique needs of women who use opioids and engage in sex trade within the criminal justice context. Recruitment targets 60 dyads (120 individuals) across a single site in Columbus, Ohio.

Why it matters

Who can join: the full rules

Inclusion Criteria for Specialty Treatment Court Participants:

* 18 years of age or older
* Identify as a woman
* meet or have met DSM5 criteria for an Opioid Use Disorder (OUD)
* report current or prior sex trade involvement
* attending a specialty treatment court / treatment diversion program
* Identify one family member able to participate

Inclusion Criteria for Family Participants

* 18 years of age or older
* Willing to participate in a hypothetical family intervention

Exclusion Criteria for Specialty Treatment Court Participants:

* Under age 18
* Non-English speaking

Exclusion Criteria for Family Participants:

* Under age 18
* Non-English Speaking

Where it's running

• The Ohio State University
  Columbus, Ohio, United States Recruiting

Study contacts

• Principal investigator: Aaron W Murnan, PhD — Ohio State University
• Study coordinator: Sandy Solove
• Email: solove.3@osu.edu
• Phone: 614-247-8366

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adaptive Decision Support for Addiction Treatment: Testing a Care Tool for ED Doctors to Help Buprenorphine Use

  We’re testing a refined decision-support tool in emergency departments to help doctors prescribe buprenorphine to adults with moderate to severe opioid use disorder.

  Recruiting at 3 sites Yale University · Guilford, Connecticut and 2 other locations · NCT07793383

• Helping rural jails use medications for opioid use disorder better

  This project tests a training program to help jail staff in rural areas start or expand medications for opioid use disorder and see if it improves public health outcomes.

  Recruiting University of Massachusetts, Worcester · Worcester, Massachusetts · NCT07637994

• Optimizing Pregnancy Care with Patient Navigation for Moms on Opioid Surgery?

  We’re testing whether patient navigation helps pregnant Medicaid members with opioid (and possibly stimulant) use disorders stay in care, use available medications, and connect with services better than usual care.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07586917

• Nalmefene implant in healthy volunteers

  This Phase 1 trial will test one or two nalmefene implants in healthy adults to see how safe they are and how the drug is absorbed and cleared from the body.

  Recruiting Phase 1 ReacX Pharmaceuticals, Inc. · Morrisville, North Carolina · NCT07325279

• Using semaglutide to help reduce opioid use in patients undergoing treatment for opioid use disorder

  This study is testing if the medication semaglutide can help adults in outpatient treatment for opioid use disorder reduce their use of illicit opioids.

  Recruiting at 3 sites Phase 2 Milton S. Hershey Medical Center · Baltimore, Maryland and 3 other locations · NCT06548490

• Examining brain activity patterns related to opioid relapse during treatment

  This study is testing how brain activity patterns might predict the risk of relapse to opioid use in people who have just started treatment with methadone or buprenorphine.

  Recruiting at 2 sites Yale University · Hartford, Connecticut and 1 other locations · NCT06651333

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.